A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"

Keywords

• Humans
• Network Meta-Analysis
• Fluticasone/therapeutic use
• *Androstadienes/therapeutic use
• Benzyl Alcohols/therapeutic use
• Chlorobenzenes/therapeutic use
• Quinuclidines/therapeutic use
• *Pulmonary Disease, Chronic Obstructive/drug therapy
• Administration, Inhalation
• Bronchodilator Agents/therapeutic use
• Drug Combinations
• Copd
• Fixed-effects model
• Fluticasone furoate/umeclidinium/vilanterol
• Heterogeneity
• Indirect treatment comparison
• Random effects model
• Triple therapy